The optimal timing for thyroidectomy in gene carriers of an RET mutation is now recommended based on the risk classification of the specific RET mutation into moderate, high and highest risk for early development of MTC (early or late penetrance) (Table 1) (1). The gene discussed is RET; the disease is medullary thyroid gland carcinoma.